Literature DB >> 28765583

Liver cancer: Translating '-omics' results into precision medicine for hepatocellular carcinoma.

Daniela Sia1, Josep M Llovet2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28765583     DOI： 10.1038/nrgastro.2017.103

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

Review 2.  Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.

Authors:  Daniela Sia; Augusto Villanueva; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2016-12-30       Impact factor: 22.682

3.  Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.

Authors:  Daniela Sia; Yang Jiao; Iris Martinez-Quetglas; Olga Kuchuk; Carlos Villacorta-Martin; Manuel Castro de Moura; Juan Putra; Genis Camprecios; Laia Bassaganyas; Nicholas Akers; Bojan Losic; Samuel Waxman; Swan N Thung; Vincenzo Mazzaferro; Manel Esteller; Scott L Friedman; Myron Schwartz; Augusto Villanueva; Josep M Llovet
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

Review 4.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Jessica Zucman-Rossi; Eli Pikarsky; Bruno Sangro; Myron Schwartz; Morris Sherman; Gregory Gores
Journal:  Nat Rev Dis Primers       Date:  2016-04-14       Impact factor: 52.329

Review 5.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

6.  Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.

Authors:  Anthony B El-Khoueiry; Bruno Sangro; Thomas Yau; Todd S Crocenzi; Masatoshi Kudo; Chiun Hsu; Tae-You Kim; Su-Pin Choo; Jörg Trojan; Theodore H Welling; Tim Meyer; Yoon-Koo Kang; Winnie Yeo; Akhil Chopra; Jeffrey Anderson; Christine Dela Cruz; Lixin Lang; Jaclyn Neely; Hao Tang; Homa B Dastani; Ignacio Melero
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

7.  Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Jordi Bruix; Shukui Qin; Philippe Merle; Alessandro Granito; Yi-Hsiang Huang; György Bodoky; Marc Pracht; Osamu Yokosuka; Olivier Rosmorduc; Valeriy Breder; René Gerolami; Gianluca Masi; Paul J Ross; Tianqiang Song; Jean-Pierre Bronowicki; Isabelle Ollivier-Hourmand; Masatoshi Kudo; Ann-Lii Cheng; Josep M Llovet; Richard S Finn; Marie-Aude LeBerre; Annette Baumhauer; Gerold Meinhardt; Guohong Han
Journal:  Lancet       Date:  2016-12-06       Impact factor: 79.321

8.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

10.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Authors: 
Journal:  Cell       Date:  2017-06-15       Impact factor: 66.850
  10 in total
  12 in total

Review 1.  Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.

Authors:  Shreya Sengupta; Neehar D Parikh
Journal:  Hepat Oncol       Date:  2017-11-17

Review 2.  Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults.

Authors:  Christopher D Woodrell; Lissi Hansen; Thomas D Schiano; Nathan E Goldstein
Journal:  Clin Ther       Date:  2018-03-20       Impact factor: 3.393

Review 3.  Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.

Authors:  William M Grady; Ming Yu; Sanford D Markowitz
Journal:  Gastroenterology       Date:  2020-12-03       Impact factor: 22.682

Review 4.  Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Authors:  Germana Castelli; Elvira Pelosi; Ugo Testa
Journal:  Cancers (Basel)       Date:  2017-09-20       Impact factor: 6.639

Review 5.  New Therapeutic Targets in Autoimmune Cholangiopathies.

Authors:  Alessio Gerussi; Martina Lucà; Laura Cristoferi; Vincenzo Ronca; Clara Mancuso; Chiara Milani; Daphne D'Amato; Sarah Elizabeth O'Donnell; Marco Carbone; Pietro Invernizzi
Journal:  Front Med (Lausanne)       Date:  2020-04-07

Review 6.  Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine.

Authors:  Yichao Wu; Zhikun Liu; Xiao Xu
Journal:  Cancer Commun (Lond)       Date:  2020-12-08

7.  IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction.

Authors:  Nicholas J W Easom; Kerstin A Stegmann; Leo Swadling; Laura J Pallett; Alice R Burton; Dennis Odera; Nathalie Schmidt; Wei-Chen Huang; Giuseppe Fusai; Brian Davidson; Mala K Maini
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 8.786

Review 8.  Dimensions of hepatocellular carcinoma phenotypic diversity.

Authors:  Romain Désert; Natalia Nieto; Orlando Musso
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742

9.  Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

Authors:  Shanzhou Huang; Chuanzhao Zhang; Chengjun Sun; Yuchen Hou; Yixi Zhang; Nga Lei Tam; Zekang Wang; Jia Yu; Bowen Huang; Hongkai Zhuang; Zixuan Zhou; Zuyi Ma; Zhonghai Sun; Xiaoshun He; Qi Zhou; Baohua Hou; Linwei Wu
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

10.  Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.

Authors:  Xiaoyi Hu; Mingyang Bao; Jiacheng Huang; Lin Zhou; Shusen Zheng
Journal:  Front Oncol       Date:  2020-09-25       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.